122 related articles for article (PubMed ID: 15086408)
1. Epstein-Barr virus-related nasal and cutaneous T-cell lymphoma in an immunosuppressed patient.
Sivaji N; Wardrop P; Vosylius P; Jarrett R
Br J Haematol; 2004 May; 125(3):266. PubMed ID: 15086408
[No Abstract] [Full Text] [Related]
2. Epstein-Barr virus and human T-cell lymphomas.
Meijer CJ; Jiwa NM; Dukers DF; Oudejans JJ; de Bruin PC; Walboomers JM; van den Brule AJ
Semin Cancer Biol; 1996 Aug; 7(4):191-6. PubMed ID: 8946603
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous dissemination of nasal NK/T-cell lymphoma in a young girl.
Sandner A; Helmbold P; Winkler M; Gattenlöhner S; Müller-Hermelink HK; Holzhausen HJ
Clin Exp Dermatol; 2008 Aug; 33(5):615-8. PubMed ID: 18616730
[TBL] [Abstract][Full Text] [Related]
4. Extranodal NK/T-cell lymphoma, nasal type, presenting after 5 years of remission.
Ito T; Okubo Y; Furuhata Y; Niide M; Kawaguchi A; Yamazaki M; Iwaya K; Tsuboi R
Int J Dermatol; 2008 Mar; 47(3):259-61. PubMed ID: 18289327
[No Abstract] [Full Text] [Related]
5. Aggressive B-cell lymphoma induced by Epstein-Barr virus infection in erythrodermic cutaneous T-cell lymphoma.
Kikuchi A; Anzai H; Kosuge H; Naka W; Nishikawa T
Br J Dermatol; 1997 Jan; 136(1):124-8. PubMed ID: 9039311
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-positive blastoid nasal T/natural killer-cell lymphoma in a caucasian.
Ling TC; Harris M; Craven NM
Br J Dermatol; 2002 Apr; 146(4):700-3. PubMed ID: 11966709
[TBL] [Abstract][Full Text] [Related]
7. [Extranodal nasal type NK/T-cell lymphoma: the expression of Epstein-Barr virus latent membrane protein 1 and its significance of prognosis].
Zhao S; Liu WP; Zhang WY; Li GD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 May; 36(3):338-40. PubMed ID: 15931862
[TBL] [Abstract][Full Text] [Related]
8. Hydroa vacciniforme-like primary cutaneous CD8-positive T-cell lymphoma.
Feng S; Jin P; Zeng X
Eur J Dermatol; 2008; 18(3):364-5. PubMed ID: 18474490
[No Abstract] [Full Text] [Related]
9. Spontaneous regression of primary cutaneous Epstein-Barr virus-positive, CD30-positive anaplastic large T-cell lymphoma in a heart-transplant recipient.
Chiu LS; Choi PC; Luk NM; Chang M; Tang WY
Clin Exp Dermatol; 2009 Jul; 34(5):e21-4. PubMed ID: 19508468
[TBL] [Abstract][Full Text] [Related]
10. Evidence for polyclonal infection of Epstein-Barr virus in a patient with primary cutaneous anaplastic large cell lymphoma.
Shimauchi T; Onoue A; Yamamoto O; Hino R; Tokura Y
Clin Exp Dermatol; 2004 Jul; 29(4):383-6. PubMed ID: 15245536
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous nasal-type CD56+ natural killer/T-cell lymphoma preceded by Epstein-Barr virus antigenaemia.
Chang SE; Choi JH; Sung KJ; Moon KC; Koh JK
Br J Dermatol; 2001 Oct; 145(4):668-9. PubMed ID: 11703301
[No Abstract] [Full Text] [Related]
12. Treatment of Epstein-Barr virus-associated peripheral T-cell lymphoma.
Imashuku S; Teramura T; Konishi K; Kikuchi A; Tamura S; Maeda Y; Kuroda H
Br J Dermatol; 2004 May; 150(5):1038-40. PubMed ID: 15149529
[No Abstract] [Full Text] [Related]
13. Presence of Epstein-Barr virus in Langerhans cells of CTCL lesions.
Knol AC; Quéreux G; Pandolfino MC; Khammari A; Dreno B
J Invest Dermatol; 2005 Jan; 124(1):280-2. PubMed ID: 15654989
[No Abstract] [Full Text] [Related]
14. A case of primary Epstein-Barr virus-associated cutaneous diffuse large B-cell lymphoma unassociated with iatrogenic or endogenous immune dysregulation.
Tokuda Y; Fukushima M; Nakazawa K; Oguchi S; Koganehira Y; Yamaura M; Iijima M; Murata H; Uhara H; Takata M; Saida T; Katsuyama T; Nakamura S
J Cutan Pathol; 2008 Jul; 35(7):666-71. PubMed ID: 18201237
[TBL] [Abstract][Full Text] [Related]
15. A case of primary cutaneous natural killer/T-cell lymphoma, nasal type, with indolent clinical course: monoclonal expansion of Epstein-Barr virus genome correlating with the terminal aggressive behaviour.
Watabe D; Kanno H; Inoue-Narita T; Onodera H; Izumida W; Kowata S; Sawai T; Akasaka T
Br J Dermatol; 2009 Jan; 160(1):205-7. PubMed ID: 18945315
[No Abstract] [Full Text] [Related]
16. A case of CD30+ nasal natural killer/T-cell lymphoma.
Ferenczi K; Summers P; Aubert P; Cooper B; Meyerson H; Cooper KD; Honda K
Am J Dermatopathol; 2008 Dec; 30(6):567-71. PubMed ID: 19033930
[TBL] [Abstract][Full Text] [Related]
17. Intravascular large T-cell or NK-cell lymphoma: a rare variant of intravascular large cell lymphoma with frequent cytotoxic phenotype and association with Epstein-Barr virus infection.
Cerroni L; Massone C; Kutzner H; Mentzel T; Umbert P; Kerl H
Am J Surg Pathol; 2008 Jun; 32(6):891-8. PubMed ID: 18425045
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus infected cells in the aqueous humour originated from nasal NK/T cell lymphoma.
Kase S; Namba K; Kitaichi N; Ohno S
Br J Ophthalmol; 2006 Feb; 90(2):244-5. PubMed ID: 16424544
[No Abstract] [Full Text] [Related]
19. L-asparaginase induced complete remission in Epstein-Barr virus positive, multidrug resistant, cutaneous T-cell lymphoma.
Obama K; Tara M; Niina K
Int J Hematol; 1999 Jun; 69(4):260-2. PubMed ID: 10407584
[TBL] [Abstract][Full Text] [Related]
20. Primary cutaneous Epstein-Barr virus-associated B-cell lymphoma arising at the site of subcutaneous injections of methotrexate.
Giard C; Avenel-Audran M; Croué A; Verret JL; Martin L
J Clin Oncol; 2010 Dec; 28(34):e717-8. PubMed ID: 20823409
[No Abstract] [Full Text] [Related]
[Next] [New Search]
